volume 33, issue 6, P524-532 2018
DOI: 10.1590/s0102-865020180060000007
View full text
Has erratum
|
|
Share

Abstract: The reduction of ventricular arrhythmias, atrioventricular block, and lethality and serum levels of creatine kinase produced by treatment with orlistat in animal model of cardiac isquemia/reperfusion injury suggest that ORL could be used as an efficient cardioprotective therapeutic strategy to attenuate myocardial damage related to acute myocardial infarction.

Editorial notices